Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 3
1969 1
1972 1
1973 1
1974 1
1975 1
1976 2
1977 1
1978 3
1979 5
1980 8
1981 9
1982 6
1983 6
1984 6
1985 12
1986 2
1987 7
1988 9
1989 7
1990 7
1991 3
1992 5
1993 6
1994 7
1995 11
1996 6
1997 9
1998 6
1999 2
2000 4
2001 7
2002 10
2003 9
2004 14
2005 17
2006 13
2007 20
2008 15
2009 18
2010 16
2011 18
2012 15
2013 26
2014 23
2015 24
2016 17
2017 15
2018 8
2019 12
2020 14
2021 18
2022 9
2023 13
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

473 results

Results by year

Filters applied: . Clear all
Page 1
Recommendations for diagnosis and treatment of methemoglobinemia.
Iolascon A, Bianchi P, Andolfo I, Russo R, Barcellini W, Fermo E, Toldi G, Ghirardello S, Rees D, Van Wijk R, Kattamis A, Gallagher PG, Roy N, Taher A, Mohty R, Kulozik A, De Franceschi L, Gambale A, De Montalembert M, Forni GL, Harteveld CL, Prchal J; SWG of red cell and iron of EHA and EuroBloodNet. Iolascon A, et al. Among authors: prchal j. Am J Hematol. 2021 Dec 1;96(12):1666-1678. doi: 10.1002/ajh.26340. Epub 2021 Sep 23. Am J Hematol. 2021. PMID: 34467556 Free PMC article. Review.
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia.
Mascarenhas J, Kosiorek HE, Prchal JT, Rambaldi A, Berenzon D, Yacoub A, Harrison CN, McMullin MF, Vannucchi AM, Ewing J, O'Connell CL, Kiladjian JJ, Mead AJ, Winton EF, Leibowitz DS, De Stefano V, Arcasoy MO, Kessler CM, Catchatourian R, Rondelli D, Silver RT, Bacigalupo A, Nagler A, Kremyanskaya M, Levine MF, Arango Ossa JE, McGovern E, Sandy L, Salama ME, Najfeld V, Tripodi J, Farnoud N, Penson AV, Weinberg RS, Price L, Goldberg JD, Barbui T, Marchioli R, Tognoni G, Rampal RK, Mesa RA, Dueck AC, Hoffman R. Mascarenhas J, et al. Among authors: prchal jt. Blood. 2022 May 12;139(19):2931-2941. doi: 10.1182/blood.2021012743. Blood. 2022. PMID: 35007321 Free PMC article. Clinical Trial.
Genetic evidence for high-altitude adaptation in Tibet.
Simonson TS, Yang Y, Huff CD, Yun H, Qin G, Witherspoon DJ, Bai Z, Lorenzo FR, Xing J, Jorde LB, Prchal JT, Ge R. Simonson TS, et al. Among authors: prchal jt. Science. 2010 Jul 2;329(5987):72-5. doi: 10.1126/science.1189406. Epub 2010 May 13. Science. 2010. PMID: 20466884
The transcriptional and regulatory identity of erythropoietin producing cells.
Kragesteen BK, Giladi A, David E, Halevi S, Geirsdóttir L, Lempke OM, Li B, Bapst AM, Xie K, Katzenelenbogen Y, Dahl SL, Sheban F, Gurevich-Shapiro A, Zada M, Phan TS, Avellino R, Wang SY, Barboy O, Shlomi-Loubaton S, Winning S, Markwerth PP, Dekalo S, Keren-Shaul H, Kedmi M, Sikora M, Fandrey J, Korneliussen TS, Prchal JT, Rosenzweig B, Yutkin V, Racimo F, Willerslev E, Gur C, Wenger RH, Amit I. Kragesteen BK, et al. Among authors: prchal jt. Nat Med. 2023 May;29(5):1191-1200. doi: 10.1038/s41591-023-02314-7. Epub 2023 Apr 27. Nat Med. 2023. PMID: 37106166
Familial MPN Predisposition.
Tashi T, Swierczek S, Prchal JT. Tashi T, et al. Among authors: prchal jt. Curr Hematol Malig Rep. 2017 Oct;12(5):442-447. doi: 10.1007/s11899-017-0414-x. Curr Hematol Malig Rep. 2017. PMID: 29027642 Review.
EnvIRONment modifies polycythemia vera.
Prchal JT, Reeves BN. Prchal JT, et al. Blood. 2023 Apr 27;141(17):2042-2044. doi: 10.1182/blood.2023020065. Blood. 2023. PMID: 37103951 Free article. No abstract available.
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea.
Yacoub A, Mascarenhas J, Kosiorek H, Prchal JT, Berenzon D, Baer MR, Ritchie E, Silver RT, Kessler C, Winton E, Finazzi MC, Rambaldi A, Vannucchi AM, Leibowitz D, Rondelli D, Arcasoy MO, Catchatourian R, Vadakara J, Rosti V, Hexner E, Kremyanskaya M, Sandy L, Tripodi J, Najfeld V, Farnoud N, Papaemmanuil E, Salama M, Singer-Weinberg R, Rampal R, Goldberg JD, Barbui T, Mesa R, Dueck AC, Hoffman R. Yacoub A, et al. Among authors: prchal jt. Blood. 2019 Oct 31;134(18):1498-1509. doi: 10.1182/blood.2019000428. Blood. 2019. PMID: 31515250 Free PMC article. Clinical Trial.
Congenital polycythemias/erythrocytoses.
Gordeuk VR, Stockton DW, Prchal JT. Gordeuk VR, et al. Among authors: prchal jt. Haematologica. 2005 Jan;90(1):109-16. Haematologica. 2005. PMID: 15642677 Review.
Hypoxia and thrombosis.
Prchal JT. Prchal JT. Blood. 2018 Jul 26;132(4):348-349. doi: 10.1182/blood-2018-06-854976. Blood. 2018. PMID: 30049732 Free article. No abstract available.
473 results